| Napoli, Raffaele |
SURPASS-EARLY, NCT05433584: A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes |
|
|
| Active, not recruiting | 4 | 780 | Europe, Canada, US, RoW | Tirzepatide, LY3298176, Antihyperglycemic medication | Eli Lilly and Company | Type 2 Diabetes | 10/25 | 11/27 | | |
| Tran, Tu-Anh |
NCT04088409 / 2019-000119-10: A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis |
|
|
| Active, not recruiting | 3 | 30 | Europe | Baricitinib, LY3009104, Adalimumab | Eli Lilly and Company | Uveitis | 07/23 | 07/28 | | |
NCT04088396 / 2017-004495-60: A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA) |
|
|
| Recruiting | 3 | 58 | Europe, Japan, RoW | Baricitinib, LY3009104, Tocilizumab | Eli Lilly and Company | Systemic Juvenile Idiopathic Arthritis | 04/26 | 05/26 | | |
| Recruiting | 3 | 190 | Europe, Japan, RoW | Baricitinib, LY3009104 | Eli Lilly and Company | Juvenile Idiopathic Arthritis | 07/31 | 07/31 | | |
DonneDVit, NCT02975492 / 2016-001807-22: Assessing the Impact of a Mode of Vitamin D Supplementation (Sequential Dose vs Daily Dose) on the Incidence of Hypercalciuria in Subjets Aged From 2 to 18 Years |
|
|
| Recruiting | N/A | 280 | Europe | Cholecalciferol sequential dose, Vitamin D, Cholecalciferol daily dose | University Hospital, Montpellier | Transient Hypercalciuria | 05/24 | 12/24 | | |
MESAJ, NCT04540432: Evolution of Intestinal Microbiota in Patients With Juvenile Spondylarthropathy According to Typology of Treatment |
|
|
| Recruiting | N/A | 25 | Europe | Stool collection at the patient's home., Blood test | Centre Hospitalier Universitaire de Nīmes, University Hospital, Montpellier, Assistance Publique Hopitaux De Marseille | Spondylarthropathies | 06/27 | 06/27 | | |
| Saccone, Gabriele |
COLORS, NCT03251729: Cerclage On LOw Risk Singletons: Cervical Cerclage for Prevention of Spontaneous Preterm Birth in Low Risk Singleton Pregnancies With Short Cervix |
|
|
| Completed | 4 | 93 | Europe, US | Cervical cerclage, Vaginal progesterone | Thomas Jefferson University | Premature Birth | 02/24 | 02/24 | | |
NCT04662424: Effect of Music in Labor in Women Who Underwent Induction of Labor |
|
|
| Recruiting | N/A | 30 | Europe | music in labor | Federico II University | Labor Pain | 02/21 | 03/21 | | |
NCT02923973: Transvaginal Ultrasound Cervical Length Screening in Singleton Pregnancy With Prior Spontaneous Preterm Birth |
|
|
| Recruiting | N/A | 500 | Europe | Transvaginal ultrasound cervical length screening | Federico II University, University of Pisa - Prof Paolo Mannella | Preterm Birth | 12/24 | 03/25 | | |
NCT03591042: Universal Transvaginal Cervical Length Screening Program for Prevention of Preterm Birth in Singletons Without Prior Preterm Birth |
|
|
| Recruiting | N/A | 1334 | Europe | cervical length screening | Federico II University | Preterm Birth | 12/21 | 03/22 | | |
NCT04205292: Cesarean Scar Pregnancy Managed by Dilatation and Evacuation (D&E) Versus Hysteroscopic Surgery |
|
|
| Recruiting | N/A | 54 | Europe | hysteroscopic | Federico II University | Scar; Previous Cesarean Section | 12/21 | 01/22 | | |
| Recruiting | N/A | 100 | Europe | PREGNOLIA SYSTEM | Federico II University | Preterm Labor, Preterm Birth | 09/22 | 12/22 | | |
NCT05449171: High Molecular Weight Hyaluronic Acid, α-lipoic Acid, Magnesium, Vitamin B6 and Vitamin D, in the Prevention of Spontaneous Abortion |
|
|
| Completed | N/A | 100 | Europe | high molecular weight hyaluronic acid, α-lipoic acid (ALA), magnesium, vitamin B6 and vitamin D | Lo.Li.Pharma s.r.l | Abortion, Spontaneous | 09/23 | 01/24 | | |
NCT06355375: Exercise in Pregnancy and Risk of Postpartum Depression |
|
|
| Recruiting | N/A | 398 | Europe | exercise in pregnancy | Federico II University | Depression, Pregnancy Related | 01/25 | 12/25 | | |
| Recruiting | N/A | 40 | Europe | Molecular and genetic screening | Federico II University, San Raffaele University Hospital, Italy, San Giuseppe Moscati Hospital | Peripartum Cardiomyopathy | 02/25 | 05/26 | | |
| Recruiting | N/A | 200 | Europe, US, RoW | Cervical cerclage | Thomas Jefferson University, Federico II University | Twin Pregnancy With Antenatal Problem, Preterm Birth, Short Cervix | 06/24 | 06/25 | | |
| Imagawa, Tomoyuki |
NCT04088396 / 2017-004495-60: A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA) |
|
|
| Recruiting | 3 | 58 | Europe, Japan, RoW | Baricitinib, LY3009104, Tocilizumab | Eli Lilly and Company | Systemic Juvenile Idiopathic Arthritis | 04/26 | 05/26 | | |
| Recruiting | 3 | 190 | Europe, Japan, RoW | Baricitinib, LY3009104 | Eli Lilly and Company | Juvenile Idiopathic Arthritis | 07/31 | 07/31 | | |
| Alessio, Maria |
NCT04527380 / 2018-000681-10: A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis |
|
|
| Active, not recruiting | 3 | 100 | Europe, RoW | Ixekizumab, LY2439821, Adalimumab | Eli Lilly and Company | Juvenile Psoriatic Arthritis, Enthesitis Related Arthritis | 02/24 | 04/28 | | |
NCT04088396 / 2017-004495-60: A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA) |
|
|
| Recruiting | 3 | 58 | Europe, Japan, RoW | Baricitinib, LY3009104, Tocilizumab | Eli Lilly and Company | Systemic Juvenile Idiopathic Arthritis | 04/26 | 05/26 | | |
| Recruiting | 3 | 190 | Europe, Japan, RoW | Baricitinib, LY3009104 | Eli Lilly and Company | Juvenile Idiopathic Arthritis | 07/31 | 07/31 | | |
| Tirosh, Irit |
NCT04088396 / 2017-004495-60: A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA) |
|
|
| Recruiting | 3 | 58 | Europe, Japan, RoW | Baricitinib, LY3009104, Tocilizumab | Eli Lilly and Company | Systemic Juvenile Idiopathic Arthritis | 04/26 | 05/26 | | |
| Recruiting | 3 | 190 | Europe, Japan, RoW | Baricitinib, LY3009104 | Eli Lilly and Company | Juvenile Idiopathic Arthritis | 07/31 | 07/31 | | |
| Salvatore, Domenico |
| Active, not recruiting | 3 | 291 | Europe, Canada, Japan, US, RoW | Selpercatinib, LY3527723, LOXO-292, Cabozantinib, Vandetanib | Loxo Oncology, Inc., Eli Lilly and Company | Medullary Thyroid Cancer | 05/23 | 02/26 | | |
| Recruiting | N/A | 15000 | Europe | Standard treatment | University of Roma La Sapienza, Italian Thyroid Cancer Observatory (ITCO) Foundation, Catholic University of the Sacred Heart | Thyroid Neoplasms | 01/25 | 01/25 | | |
| Breda, Luciana |
NCT04088396 / 2017-004495-60: A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA) |
|
|
| Recruiting | 3 | 58 | Europe, Japan, RoW | Baricitinib, LY3009104, Tocilizumab | Eli Lilly and Company | Systemic Juvenile Idiopathic Arthritis | 04/26 | 05/26 | | |
| Recruiting | 3 | 190 | Europe, Japan, RoW | Baricitinib, LY3009104 | Eli Lilly and Company | Juvenile Idiopathic Arthritis | 07/31 | 07/31 | | |
| Recruiting | N/A | 3500 | Europe, US, RoW | No intervention is foreseen by the protocol. | University of Siena | Hereditary Autoinflammatory Diseases, Schnitzler Syndrome, Behcet Syndrome, PFAPA Syndrome, Still Disease, Autoinflammatory Syndrome, Unspecified, Uveitis, Scleritis, Vexas Syndrome | 08/23 | 08/30 | | |
| Lovillo, Marisol Comacho |
NCT04527380 / 2018-000681-10: A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis |
|
|
| Active, not recruiting | 3 | 100 | Europe, RoW | Ixekizumab, LY2439821, Adalimumab | Eli Lilly and Company | Juvenile Psoriatic Arthritis, Enthesitis Related Arthritis | 02/24 | 04/28 | | |
NCT04088396 / 2017-004495-60: A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA) |
|
|
| Recruiting | 3 | 58 | Europe, Japan, RoW | Baricitinib, LY3009104, Tocilizumab | Eli Lilly and Company | Systemic Juvenile Idiopathic Arthritis | 04/26 | 05/26 | | |
| Recruiting | 3 | 190 | Europe, Japan, RoW | Baricitinib, LY3009104 | Eli Lilly and Company | Juvenile Idiopathic Arthritis | 07/31 | 07/31 | | |
| Yokoyama, Tadafumi |
| Recruiting | 3 | 190 | Europe, Japan, RoW | Baricitinib, LY3009104 | Eli Lilly and Company | Juvenile Idiopathic Arthritis | 07/31 | 07/31 | | |
| Ramaglia, Luca |
NCT05942794: Identification of Oral Lesions Through an Autofluorescence System |
|
|
| Recruiting | N/A | 200 | Europe | Screening examination | Federico II University | Oral Leukoplakia, Autofluorescence, Secondary Prevention, Keratosis, Oral Lichen Planus, Oral Cancer, Oral Disease | 03/24 | 10/24 | | |
NCT05188898: Treatment of Intraosseous Periodontal Defects With Hyaluronic Acid |
|
|
| Completed | N/A | 22 | Europe | MINSD and Hyaluronic acid, MINSD | Federico II University | Periodontal Bone Loss, Periodontal Pocket | 03/23 | 03/23 | | |
NCT05073575: Application of Hyaluronic Acid in the Treatment of Periodontitis |
|
|
| Recruiting | N/A | 80 | Europe | Hyaluronic acid, No-hyaluronic acid | Federico II University | Periodontal Bone Loss | 07/24 | 10/24 | | |
NCT05315804: Treatment of Intraosseous Periodontal Defects With Amelogenins |
|
|
| Recruiting | N/A | 22 | Europe | MINSD and amelogenins, MINSD | Federico II University | Periodontal Bone Loss, Periodontal Pocket | 07/24 | 10/24 | | |
NCT05926557: Treatment of Peri-implant Mucositis by Application of a Spermidine-based Gel |
|
|
| Recruiting | N/A | 20 | Europe | Spermidine gel, NSMD | Federico II University | Peri-implant Mucositis, Mucositis Oral | 06/24 | 06/24 | | |
NCT05926297: Treatment of Peri-implant Mucositis by Sodium Hypochlorite Gel and Cross-linked Hyaluronic Acid Gel |
|
|
| Recruiting | N/A | 92 | Europe | Application NaOCl gel + HA gel, Non-surgical mechanical debridement | Federico II University, Semmelweis University | Peri-implant Mucositis, Mucositis Oral | 06/24 | 01/25 | | |
| Maggio, Maria Cristina |
NCT04088396 / 2017-004495-60: A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA) |
|
|
| Recruiting | 3 | 58 | Europe, Japan, RoW | Baricitinib, LY3009104, Tocilizumab | Eli Lilly and Company | Systemic Juvenile Idiopathic Arthritis | 04/26 | 05/26 | | |
| Recruiting | 3 | 190 | Europe, Japan, RoW | Baricitinib, LY3009104 | Eli Lilly and Company | Juvenile Idiopathic Arthritis | 07/31 | 07/31 | | |
NCT06305611: European and North Indian Cohort of KaWasaki dIsease |
|
|
| Recruiting | N/A | 103 | Europe, RoW | | Meyer Children's Hospital IRCCS | Kawasaki Disease | 07/24 | 10/24 | | |
| Recruiting | N/A | 3500 | Europe, US, RoW | No intervention is foreseen by the protocol. | University of Siena | Hereditary Autoinflammatory Diseases, Schnitzler Syndrome, Behcet Syndrome, PFAPA Syndrome, Still Disease, Autoinflammatory Syndrome, Unspecified, Uveitis, Scleritis, Vexas Syndrome | 08/23 | 08/30 | | |
| Recruiting | N/A | 113 | Europe | Sexual Nursing care, Standard Nursing Care | IRCCS Centro Neurolesi "Bonino-Pulejo" | Stroke | 06/24 | 04/25 | | |
| Recruiting | N/A | 40 | Europe | Intensive Neurowave Emotional Stimulation (INES), Intensive Sensorial Emotional Stimulation (ISES), traditional rehabilitation | IRCCS Centro Neurolesi "Bonino-Pulejo" | Disorders of Consciousness | 12/24 | 09/25 | | |
| Recruiting | N/A | 480 | Europe | Telerehabilitation with Virtual Reality, Traditional Cognitive Rehabilitation | IRCCS Centro Neurolesi Bonino Pulejo | Cognitive Dysfunction, Subjective Health, Mild Cognitive Impairment, Alzheimer Disease, Parkinson Disease | 01/26 | 01/26 | | |
| Adamo, Daniela |
NCT06025474: Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth Syndrome |
|
|
| Recruiting | 3 | 203 | Europe | Vortioxetine 20Mg Tab, Brintellix, Paroxetine 20 Mg Oral Tablet, Sertraline 50 MG, Citalopram 20mg, Escitalopram 10mg, Duloxetine 60 MG, Pregabalin 75mg | Federico II University | Burning Mouth Syndrome | 10/23 | 07/24 | | |
| Haviv, Ruby |
NCT04088396 / 2017-004495-60: A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA) |
|
|
| Recruiting | 3 | 58 | Europe, Japan, RoW | Baricitinib, LY3009104, Tocilizumab | Eli Lilly and Company | Systemic Juvenile Idiopathic Arthritis | 04/26 | 05/26 | | |
| Recruiting | 3 | 190 | Europe, Japan, RoW | Baricitinib, LY3009104 | Eli Lilly and Company | Juvenile Idiopathic Arthritis | 07/31 | 07/31 | | |
NCT06305611: European and North Indian Cohort of KaWasaki dIsease |
|
|
| Recruiting | N/A | 103 | Europe, RoW | | Meyer Children's Hospital IRCCS | Kawasaki Disease | 07/24 | 10/24 | | |
| Zizolfi, Brunella Ms |
NCT06524934: Virtual Reality's Role in See&Treat Hysteroscopy |
|
|
| Completed | N/A | 116 | Europe | Use of virtual reality during the hysteroscopic procedure | Federico II University | Endometrial Cancer, Endometrial Diseases, Myoma;Uterus, Endometrial Hyperplasia | 07/24 | 07/24 | | |
| Laneri, Sonia |
NCT06674005: Cucurbita Pepo Flowers Extract to Promote Skin Health |
|
|
| Completed | N/A | 40 | Europe | Cucurbita pepo L. Flowers Extract, Placebo | Ritamaria Di Lorenzo | Skin Laxity, Skin Aging, Skin Wrinkling | 12/22 | 01/23 | | |
